DIVIGEL Trademark

Trademark Overview

On Thursday, March 29, 2001, a trademark application was filed for DIVIGEL with the United States Patent and Trademark Office. The USPTO has given the DIVIGEL trademark a serial number of 76232382. The federal status of this trademark filing is REGISTERED AND RENEWED as of Sunday, February 11, 2024. This trademark is owned by Orion Corporation. The DIVIGEL trademark is filed in the Pharmaceutical Products category with the following description:

PRESCRIPTION PHARMACEUTICAL PREPARATIONS FOR HORMONE REPLACEMENT THERAPY AND FOR THE PREVENTION OF OSTEOPOROSIS
divigel

General Information

Serial Number76232382
Word MarkDIVIGEL
Filing DateThursday, March 29, 2001
Status800 - REGISTERED AND RENEWED
Status DateSunday, February 11, 2024
Registration Number2687997
Registration DateTuesday, February 18, 2003
Mark Drawing1000 - Typeset: Word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, July 16, 2002

Trademark Statements

Goods and ServicesPRESCRIPTION PHARMACEUTICAL PREPARATIONS FOR HORMONE REPLACEMENT THERAPY AND FOR THE PREVENTION OF OSTEOPOROSIS

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, April 9, 2001
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameOrion Corporation
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressEspoo 02200
FI
Party NameOrion Corporation
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
Address02200 Espoo
FI
Party NameOrion Corporation
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
Address02200 Espoo
FI

Trademark Events

Event DateEvent Description
Sunday, February 11, 2024NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Sunday, February 11, 2024REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
Sunday, February 11, 2024REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Sunday, February 11, 2024CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Thursday, August 17, 2023TEAS SECTION 8 & 9 RECEIVED
Friday, February 18, 2022COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Thursday, January 3, 2013NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Thursday, January 3, 2013SEC. 15 ACKNOWLEDGEMENT - E-MAILED
Thursday, January 3, 2013REGISTERED - SEC. 15 ACKNOWLEDGED
Thursday, January 3, 2013REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Thursday, January 3, 2013REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Thursday, January 3, 2013CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Monday, December 10, 2012TEAS SECTION 8 & 9 RECEIVED
Monday, December 10, 2012TEAS SECTION 15 RECEIVED
Friday, June 4, 2010REGISTERED - SEC. 8 (6-YR) ACCEPTED
Thursday, January 29, 2009REGISTERED - SEC. 8 (6-YR) FILED
Monday, November 9, 2009PAPER RECEIVED
Friday, October 23, 2009TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, May 8, 2009POST REGISTRATION ACTION MAILED - SEC. 8
Tuesday, February 3, 2009ASSIGNED TO PARALEGAL
Thursday, January 29, 2009TEAS SECTION 8 RECEIVED
Wednesday, March 26, 2008CASE FILE IN TICRS
Tuesday, February 18, 2003REGISTERED-PRINCIPAL REGISTER
Monday, August 19, 2002EXTENSION OF TIME TO OPPOSE RECEIVED
Tuesday, July 16, 2002PUBLISHED FOR OPPOSITION
Wednesday, June 26, 2002NOTICE OF PUBLICATION
Wednesday, February 20, 2002APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, November 19, 2001CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, June 21, 2001CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, January 28, 2002Sec. 1(B) CLAIM DELETED
Monday, August 6, 2001NON-FINAL ACTION MAILED
Thursday, July 12, 2001ASSIGNED TO EXAMINER

Related Keywords

divigel therapy prevention osteoporosis replacement hormone pharmaceutical preparations prescription